Pfizer Inc. (FRA:PFE)
Germany
· Delayed Price · Currency is EUR | Market Cap | 125.30B |
| Revenue (ttm) | 53.69B |
| Net Income (ttm) | 8.41B |
| Shares Out | n/a |
| EPS (ttm) | 1.48 |
| PE Ratio | 14.91 |
| Forward PE | 8.62 |
| Dividend | 1.53 (6.96%) |
| Ex-Dividend Date | Nov 7, 2025 |
| Volume | 5,821 |
| Average Volume | 15,906 |
| Open | 21.98 |
| Previous Close | 22.04 |
| Day's Range | 21.97 - 22.27 |
| 52-Week Range | 18.77 - 26.50 |
| Beta | n/a |
| RSI | 56.97 |
| Earnings Date | Feb 3, 2026 |
About Pfizer
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]
Financial Performance
In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.
Financial numbers in USD Financial StatementsNews
Do These 3 Healthcare Stocks Need a Checkup?
Pfizer has a sizable 6.8% yield and is down nearly 60% from its 2021 highs. Bristol Myers Squibb has a 5% yield and is off its 2023 highs by nearly 40%.
Smart Money Is Betting Big In PFE Options
Financial giants have made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer (NYSE: PFE) revealed 20 unusual trades. Delving into the details, we found 35% of traders w...
2 Headwinds Facing Pfizer Stock Going Into 2026
There is plenty to be wary of with this drugmaker, but there are also reasons to be optimistic.
Pfizer: The Market Is Still Wrong About It
Pfizer stock offers 30% upside with strong non-COVID franchises, margin expansion, and pipeline potential. Click here to read my latest analysis of PFE stock.
PFE June 2027 Options Begin Trading
Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the June 2027 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is th...
17 dividend-stock bargains from a value manager with a stellar track record
John Buckingham, editor of the Prudent Speculator, reminds investors to be “willing to stomach volatility.”
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
PFE: Citigroup Reinstates Neutral Rating with a $26 PT | PFE Stock News
PFE: Citigroup Reinstates Neutral Rating with a $26 PT | PFE Stock News
Pre-Market Most Active for Dec 2, 2025 : INTC, EB, TSLL, TQQQ, NVDA, IREN, IBIT, SMFG, NIO, T, INVH, PFE
The NASDAQ 100 Pre-Market Indicator is up 119 to 25,461.85. The total Pre-Market volume is currently 97,034,402 shares traded.The following are the most active stocks for the pre-market session: Intel...
How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint
Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam Pharmaceuticals.
2 Top Dividend Stocks to Buy Now and Hold For a Decade
Pfizer's strategy that will help it rebound from recent struggles is in full motion. It says a lot that the company continues to grow its dividend through tough times.
Pfizer (PFE) Coverage Resumed by Citi with 'Neutral' Rating
Pfizer (PFE) Coverage Resumed by Citi with 'Neutral' Rating
FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks
A report that vaccine approvals could be set to get stricter is pressuring shares of major vaccine makers.
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men
Memo also reportedly mentions vaccines for flu and pneumonia.
Pfizer (PFE) Part of UK-US Drug Pricing Agreement
Pfizer (PFE) Part of UK-US Drug Pricing Agreement
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 8:00 a.m. EST on Tuesday, D...
2 Undervalued, High-Quality Companies to Buy Now and Hold Forever
Drug companies face fairly normal industry dynamics that can leave them unloved on Wall Street over short periods of time. Pfizer is facing a patent cliff and is making a big move to revamp its drug p...
This 7% Yielder Could Be a Top AI Play
A looming patent cliff in which Pfizer will lose patent exclusivity to a handful of drugs has combined with cratering revenue from COVID-19 treatments to drive Pfizer shares down 50% since 2022. Pfize...
3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio
Intuitive Surgical shows why now is a good time to consider buying surgical-robot competitor Medtronic. Eli Lilly helps explain why down-and-out drugmaker Pfizer could be worth a close look for long-t...
Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters
Pfizer remains a compelling bargain, supported by a strong dividend yield and undervalued financial metrics, despite post-pandemic headwinds. PFE's acquisition of Metsera positions it for growth in th...
Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December
This is my latest article, where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. Most of the dividend increases announced in the last two ...
After Hours Most Active for Nov 28, 2025 : HBI, NVDA, SNAP, NEOG, MOS, INTC, AAPL, PFE, QQQ, CCL, AVTR, MSFT
The NASDAQ 100 After Hours Indicator is down -1.79 to 25,433.1. The total After hours volume is currently 95,876,785 shares traded.The following are the most active stocks for the after hours session:...
8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills
Eight of the top fifteen Barron's Better Bets (BBB) 'Safer' dividend stocks, including Conagra, Altria, and Verizon, are currently attractively priced for income investors. Analyst forecasts project n...
8 Dividend Stocks Every Investor Should Consider
Dividend investing isn't just about yield -- payout ratio and growth potential matter too. Several of these companies have increased dividends for decades without interruption.
Novo Nordisk or Pfizer: Which Healthcare Giant Is the Better Bet?
PFE's oncology gains and obesity re-entry contrast with NVO's GLP-1 pressures in this in-depth comparison of two healthcare giants.